MedPath

福建省泉州海峡制药有限公司

Ownership
-
Established
2000-08-02
Employees
-
Market Cap
-
Website
www.haixiazhiyao.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

57

NMPA:57

Drug Approvals

Secnidazole Capsules

Product Name
塞克硝唑胶囊
Approval Number
国药准字H20080455
Approval Date
Feb 5, 2024
NMPA

Secnidazole Tablets

Product Name
西尼迪
Approval Number
国药准字H20060791
Approval Date
Aug 4, 2021
NMPA

Compound Quinine Injection

Product Name
复方奎宁注射液
Approval Number
国药准字H35021374
Approval Date
Nov 11, 2020
NMPA

Ethylenediamine Diaceturate Injection

Product Name
二乙酰氨乙酸乙二胺注射液
Approval Number
国药准字H20054832
Approval Date
Nov 11, 2020
NMPA

Cefaclor Capsules

Product Name
头孢克洛胶囊
Approval Number
国药准字H20054887
Approval Date
Jul 22, 2020
NMPA

Rifandin Capsiles

Product Name
利福定胶囊
Approval Number
国药准字H35021313
Approval Date
Jun 17, 2020
NMPA

Ethacridine Lactate Plasters

Product Name
乳酸依沙吖啶贴
Approval Number
国药准字H35021331
Approval Date
Jun 17, 2020
NMPA

Pipemidic Acid Capsules

Product Name
吡哌酸胶囊
Approval Number
国药准字H35021507
Approval Date
Jun 17, 2020
NMPA

Sucralfate Capsules

Product Name
硫糖铝胶囊
Approval Number
国药准字H35021500
Approval Date
Jun 17, 2020
NMPA

Nicardipine Hydrochloride Injection

Product Name
盐酸尼卡地平注射液
Approval Number
国药准字H20066367
Approval Date
Jan 16, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.